Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date
-
Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date
-
Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018
-
Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018
-
Apricus Biosciences (APRI) Announces Merger Agreement with Seelos Therapeutics
-
Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
-
Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
-
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results:
-
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
-
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
-
Pre-Open Movers 03/09: (APRI) (VVUS) (ELF) Higher; (TLRD) (SPPI) (RATE) Lower (more...)
-
Apricus Biosciences to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Apricus Biosciences to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Pre-Open Stock Movers 02/04: (NES) (ENTR) (SJM) Higher; (RL) (GLID) (SPLS) Lower (more...)
-
Apricus Biosciences to Present at the Canaccord Genuity 34th Annual Growth Conference
-
Unusual 11 Mid-Day Movers 04/16: (ZLCS) (AKBA) (IMGN) Higher; (XGTI) (AEM) (ZN) Lower

